AXSM Operating Cash Flow Growth
Axsome Therapeutics Inc · Operating Cash Flow Growth
AXSM Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported40.93%period ending
AXSM TTM Cash from Operations YoY % (-61.84% → 40.93%)
Year-over-year change
High-resolution chart · PNG
AXSM operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 40.9281% | |
| 40.2204% | |
| 27.2603% | |
| 23.8485% | |
| 27.9759% | |
| 38.6082% | |
| 11.4902% | |
| 6.8254% | |
| -50.2245% | |
| -114.9069% | |
| -24.5206% | |
| -20.7943% | |
| 8.4685% | |
| 21.1013% | |
| -7.6553% | |
| -17.8603% | |
| -37.0194% | |
| -37.9427% | |
| -37.9435% | |
| -32.4215% | |
| -26.3416% | |
| -36.9912% | |
| -69.1784% | |
| -95.5093% | |
| -107.6388% | |
| -82.9769% | |
| -54.3073% | |
| -45.3877% | |
| -25.1072% | |
| -23.9738% | |
| -13.5316% | |
| 3.0883% | |
| -5.1813% | |
| -10.6197% | |
| -24.3892% | |
| -67.9208% | |
| -91.6707% | |
| -134.3636% | |
| -186.0778% | |
| -128.6673% | |
| -107.6547% | |
| -102.158% | |
| -61.8441% |